SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eikon Therapeutics to Participate in November Investor Conferences

Eikon Therapeutics CEO Roger M. Perlmutt is scheduled to participate in multiple investor conferences in November.

EIKN

Related stories